Oramed Pharmaceuticals Inc. is a New York-based company that conducts research and development of pharmaceutical solutions for diabetes treatment using oral capsules or pills. Its flagship product, ORMD-0801, recently finished phase II clinical trials to treat individuals with diabetes. Additionally, the company is developing ORMD-0901, an oral capsule for patients with type 2 diabetes, and an oral leptin capsule for weight loss treatment.